PT Itama Ranoraya Tbk (ISX:IRRA) Total Receivables: Rp510,723 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:IRRA PT Itama Ranoraya Tbk ISX:IRRA
81 GF Score
Price Rp374.00
GF Value Rp537.62
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is PT Itama Ranoraya Tbk Total Receivables?

PT Itama Ranoraya Tbk ISX:IRRA -1.06% 81 Total Receivables is Rp510,723 Mil as of Mar. 2026. GuruFocus rates ISX:IRRA with a GF Score™ of 81/100 and a GF Value™ of Rp537.62 (Possible Value Trap). The stock has 8 warning signs investors should review.

PT Itama Ranoraya Tbk's Total Receivables for the quarter that ended in Mar. 2026 was Rp510,723 Mil.

PT Itama Ranoraya Tbk Total Receivables Related Terms

PT Itama Ranoraya Tbk Total Receivables Historical Data

* Premium members only.

The historical data trend for PT Itama Ranoraya Tbk's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Itama Ranoraya Tbk Total Receivables Chart

PT Itama Ranoraya Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 140,665.01 229,449.82 525,477.61 471,443.16 484,992.41

PT Itama Ranoraya Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 538,533.53 465,473.66 987,934.89 484,992.41 510,723.06
ISX:IRRA
81GF Score
PT Itama Ranoraya Tbk ISX:IRRA
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Itama Ranoraya Tbk Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of Rp510,723 Mil mean?
PT Itama Ranoraya Tbk (ISX:IRRA) has a Total Receivables of Rp510,723 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on PT Itama Ranoraya Tbk and its competitors.
Is PT Itama Ranoraya Tbk's Total Receivables too high?
PT Itama Ranoraya Tbk's current Total Receivables is Rp510,723 Mil. Overall, PT Itama Ranoraya Tbk has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Itama Ranoraya Tbk's Total Receivables compare to MCK and CAH?
PT Itama Ranoraya Tbk's Total Receivables of Rp510,723 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Distribution company?
A good Total Receivables depends on the Medical Distribution industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on PT Itama Ranoraya Tbk and its competitors. PT Itama Ranoraya Tbk's current Total Receivables is Rp510,723 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Itama Ranoraya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk (ISX:IRRA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp537.62, compared to a current price of Rp374.00 — trading 30.4% below its estimated fair value. The current Total Receivables is Rp510,723 Mil. PT Itama Ranoraya Tbk's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For PT Itama Ranoraya Tbk (ISX:IRRA), the current Total Receivables is Rp510,723 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Itama Ranoraya Tbk (ISX:IRRA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Itama Ranoraya Tbk stock appears to be undervalued. The current stock price of Rp374.00 is trading 30.4% below its estimated GF Value™ of Rp537.62. GuruFocus considers PT Itama Ranoraya Tbk to be Possible Value Trap.

Key valuation signals for ISX:IRRA:

  • Total Receivables: Rp510,723 Mil
  • GF Value™: Rp537.62 vs. price of Rp374.00 (30.4% below fair value)
  • GF Score™: 81/100 with 8 warning signs

No single metric tells the full story. See the ISX:IRRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Itama Ranoraya Tbk Business Description

Address Jl. KH. Teacher Amin No. 18, ITS Tower Lt.21 Nifarro Park, Sunday market, South Jakarta, Jakarta, IDN, 12510
PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. It business segment includes Vitro Diagnostic Products, Non-Electromedical Sterile Medical Devices, Electromedical Sterile Medical Devices and Other Segments. The key revenue generating segments of the company are In Vitro Diagnostic product.
81GF Score

Get the complete analysis for ISX:IRRA

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp374.00
Price
Rp537.62
GF Value